Nobel Prize Recognizes Groundbreaking Body's Defenses Research

The prestigious award in medical science was granted for revolutionary findings that illuminate how the body's defense network targets harmful pathogens while sparing the healthy tissues.

A trio of esteemed scientists—from Japan Shimon Sakaguchi and American scientists Dr. Brunkow and Fred Ramsdell—share this honor.

Their research uncovered unique "security guards" within the defense system that remove rogue defense cells capable of harming the body.

The findings are now enabling innovative therapies for immune disorders and malignancies.

These laureates will share a monetary award worth 11m SEK.

Crucial Findings

"Their research has been decisive for understanding how the immune system functions and why we don't all suffer from serious autoimmune diseases," commented the head of the Nobel Committee.

The team's studies explain a fundamental question: How does the immune system protect us from numerous infections while keeping our healthy cells intact?

Our immune system uses immune cells that scan for indicators of infection, even viruses and germs it has never encountered.

Such cells employ sensors—known as receptors—that are generated by chance in countless variations.

This gives the defense network the capacity to combat a wide array of invaders, but the unpredictability of the process inevitably creates immune cells that may attack the host.

Protectors of the Body

Researchers previously knew that some of these problematic defense cells were destroyed in the thymus—where immune cells develop.

The latest award honors the identification of regulatory T-cells—described as the body's "peacekeepers"—which patrol the body to disarm any immune cells that assault the healthy cells.

We know that this mechanism malfunctions in autoimmune diseases such as type-1 diabetes, MS, and rheumatoid arthritis.

A Nobel panel stated, "The findings have established a novel area of research and accelerated the creation of new treatments, for example for tumors and autoimmune diseases."

In malignancies, T-regs prevent the system from attacking the growth, so studies are aimed at reducing their quantity.

For self-attack disorders, experiments are testing boosting regulatory T-cells so the organism is not being harmed. A similar method could also be useful in minimizing the risks of organ transplant rejection.

Innovative Studies

Professor Sakaguchi, from a Japanese institution, performed tests on rodents that had their thymus removed, leading to autoimmune disease.

The researcher demonstrated that injecting immune cells from healthy animals could prevent the disease—suggesting there was a system for preventing defenders from attacking the body.

Dr. Brunkow, affiliated with the a research center in a US city, and Fred Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were investigating an genetic immune disorder in mice and humans that resulted in the identification of a genetic factor critical for the way T-regs function.

"Their pioneering research has revealed how the body's defenses is kept in check by T-reg cells, preventing it from accidentally attacking the healthy cells," said a leading physiology specialist.

"The research is a striking example of how basic biological research can have far-reaching implications for public health."